APPLIED CLINICAL TRIALS Issue Alert Having trouble viewing this email? Click here
Web Version | View Digital Edition | Subscribe
In our April issue:

FEATURED

Optimizing RWE Generation
Rob Sambrook
Studies designed to incorporate real-world evidence are, in the scheme of clinical research, relatively straightforward to conduct. Yet, as explored here, it is important to involve epidemiologists in these studies from their inception to help minimize bias and ensure external validity.

FDA's 'Real-World' Framework
Beth Schurman
This report examines the scope of FDA's proposed Real-World Evidence Program—its draft framework for using RWE to support new drug approvals—and the potential implications for pharmaceutical manufacturers.

Research Data: The Quest to Standardize
Barbara Jauregui, Lynn D. Hudson, Lauren B. Becnel, Eileen Navarro Almario, Ronald Fitzmartin, Frank Pétavy, Nathalie Seigneuret, James K. Malone, Fang Liz Zhou, Jose Galvez, Tammy Jackson, Nicole Harmon, Rebecca D. Kush
Clinical research is only as effective as its ability to impact and benefit health and patients at large. Authors present the latest government, industry, and public health efforts to promote global common standards in the collection and sharing of clinical trial data.

NEWS

Washington Report: Jill Wechsler on FDA's push to broaden outmoded eligibility criterial for clinical trial participation.

EU Report: Peter O'Donnell looks at the communication gaps in relaying the role and importance of translational research in Europe.

Q&A: An industry leader in the regenerative medicine space discusses recent advances in stem cell therapy development.

CLOSING THOUGHT

The 'Citizen Data Scientist'
Derek Lawrence
As clinical trials move to more agile means of data capture, the use of non-data scientists—or citizen data scientists—to handle the less complicated work in data management is on the rise.
View the digital Issue
image
 
BLOGS
Turn to ClinRegs for International Clinical Research Requirements
Reimagining Integration for Quality Clinical Trials
FDA Moves to Modernize Drug Review Process
WEBCAST
Technology: Friend vs. Foe
Get a first-hand look at the key technology considerations and best practices for executing a risk-based monitoring strategy in your clinical trial.

If you would like to submit an article to Applied Clinical Trials, contact Lisa Henderson, Editorial Director - lisa.henderson@ubm.com

Applied Clinical Trials is free to qualified subscribers. To subscribe, click here.

Click here to contact the Applied Clinical Trials sales team.

Twitter LinkedIn